Peter Olagunju - Jul 26, 2021 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role
Chief Technical Officer
Signature
/s/ Margaret Siegel as Attorney-In-Fact
Stock symbol
TCRR
Transactions as of
Jul 26, 2021
Transactions value $
$0
Form type
4
Date filed
7/27/2021, 05:19 PM
Next filing
Dec 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (Right to Buy) Award $0 +286K $0.00 286K Jul 26, 2021 Common Stock 286K $12.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on July 26, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.